化疗是临床上常见的疾病治疗方法,但化疗药物对患者的生理机能会造成一定的影响和伤害,其中血小板减少症是较为常见的不良反应,血小板减少严重可能引起患者出血甚至危及生命,对后续治疗产生一定的影响[1]。化疗所致的血小板减少症是临床上一个较为棘手的问题,它会影响化疗的正常进行,进而对治疗效果造成一定的影响,是导致化疗患者死亡的主要原因之一[2]。对化疗所致血小板减少症患者实施的常用治疗方法有输注血小板、重组人 Chemotherapy is a common clinical treatment of diseases, but the chemotherapy drugs on the physiological function of patients will cause some damage and impact, including thrombocytopenia is a more common adverse reactions, severe thrombocytopenia may cause bleeding and even life-threatening to follow-up Treatment has a certain impact [1]. Chemotherapy-induced thrombocytopenia is a clinically troublesome problem that affects the normal course of chemotherapy, which in turn has some impact on the treatment effect, which is one of the major causes of death in patients with chemotherapy [2]. Chemotherapy-induced thrombocytopenia in patients with common methods of treatment of platelet transfusion, recombinant human